Curaleaf Holdings, Inc.

TSX:CURA Stock Report

Market Cap: CA$1.6b

Curaleaf Holdings Management

Management criteria checks 2/4

Curaleaf Holdings' CEO is Boris Jordan, appointed in Aug 2024, has a tenure of less than a year. total yearly compensation is $12.35M, comprised of 6.1% salary and 93.9% bonuses, including company stock and options. directly owns 17.37% of the company’s shares, worth CA$285.14M. The average tenure of the management team and the board of directors is 2.3 years and 5.5 years respectively.

Key information

Boris Jordan

Chief executive officer

US$12.4m

Total compensation

CEO salary percentage6.1%
CEO tenureless than a year
CEO ownership17.4%
Management average tenure2.3yrs
Board average tenure5.5yrs

Recent management updates

Recent updates

Here's Why Curaleaf Holdings (TSE:CURA) Has A Meaningful Debt Burden

Dec 15
Here's Why Curaleaf Holdings (TSE:CURA) Has A Meaningful Debt Burden

Investors Give Curaleaf Holdings, Inc. (TSE:CURA) Shares A 27% Hiding

Nov 09
Investors Give Curaleaf Holdings, Inc. (TSE:CURA) Shares A 27% Hiding

Curaleaf Holdings, Inc. (TSE:CURA) Shares Slammed 25% But Getting In Cheap Might Be Difficult Regardless

Aug 13
Curaleaf Holdings, Inc. (TSE:CURA) Shares Slammed 25% But Getting In Cheap Might Be Difficult Regardless

These 4 Measures Indicate That Curaleaf Holdings (TSE:CURA) Is Using Debt Extensively

Jul 19
These 4 Measures Indicate That Curaleaf Holdings (TSE:CURA) Is Using Debt Extensively

Some Confidence Is Lacking In Curaleaf Holdings, Inc. (TSE:CURA) As Shares Slide 27%

Jun 14
Some Confidence Is Lacking In Curaleaf Holdings, Inc. (TSE:CURA) As Shares Slide 27%

Subdued Growth No Barrier To Curaleaf Holdings, Inc. (TSE:CURA) With Shares Advancing 25%

Jan 19
Subdued Growth No Barrier To Curaleaf Holdings, Inc. (TSE:CURA) With Shares Advancing 25%

Does Curaleaf Holdings (CSE:CURA) Have A Healthy Balance Sheet?

Dec 11
Does Curaleaf Holdings (CSE:CURA) Have A Healthy Balance Sheet?

Is Curaleaf Holdings (CSE:CURA) Using Too Much Debt?

Sep 08
Is Curaleaf Holdings (CSE:CURA) Using Too Much Debt?

Curaleaf Holdings (CSE:CURA) Has Debt But No Earnings; Should You Worry?

May 28
Curaleaf Holdings (CSE:CURA) Has Debt But No Earnings; Should You Worry?

We Think Curaleaf Holdings (CSE:CURA) Is Taking Some Risk With Its Debt

Sep 05
We Think Curaleaf Holdings (CSE:CURA) Is Taking Some Risk With Its Debt

Here's Why Curaleaf Holdings (CSE:CURA) Has A Meaningful Debt Burden

May 20
Here's Why Curaleaf Holdings (CSE:CURA) Has A Meaningful Debt Burden

Is Curaleaf Holdings (CSE:CURA) A Risky Investment?

Oct 26
Is Curaleaf Holdings (CSE:CURA) A Risky Investment?

CEO Compensation Analysis

How has Boris Jordan's remuneration changed compared to Curaleaf Holdings's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$206m

Jun 30 2024n/an/a

-US$221m

Mar 31 2024n/an/a

-US$237m

Dec 31 2023US$12mUS$750k

-US$230m

Sep 30 2023n/an/a

-US$346m

Jun 30 2023n/an/a

-US$318m

Mar 31 2023n/an/a

-US$268m

Dec 31 2022US$3mUS$750k

-US$258m

Sep 30 2022n/an/a

-US$157m

Jun 30 2022n/an/a

-US$202m

Mar 31 2022n/an/a

-US$223m

Dec 31 2021US$3mUS$750k

-US$206m

Sep 30 2021n/an/a

-US$164m

Jun 30 2021n/an/a

-US$90m

Mar 31 2021n/an/a

-US$57m

Dec 31 2020US$2mUS$500k

-US$57m

Sep 30 2020n/an/a

-US$52m

Jun 30 2020n/an/a

-US$50m

Mar 31 2020n/an/a

-US$72m

Dec 31 2019US$750kUS$500k

-US$67m

Sep 30 2019n/an/a

-US$57m

Jun 30 2019n/an/a

-US$84m

Mar 31 2019n/an/a

-US$64m

Dec 31 2018US$2mUS$500k

-US$56m

Sep 30 2018n/an/a

-US$40m

Jun 30 2018n/an/a

-US$6m

Mar 31 2018n/an/a

-US$3m

Dec 31 2017US$94kn/a

-US$3m

Compensation vs Market: Boris's total compensation ($USD12.35M) is above average for companies of similar size in the Canadian market ($USD1.83M).

Compensation vs Earnings: Boris's compensation has increased whilst the company is unprofitable.

CEO

Boris Jordan (58 yo)

less than a year

Tenure

US$12,352,753

Compensation

Mr. Boris Alexis Jordan is Executive Chairman of the Board at Curaleaf, Inc. and serves as its CEO since 2024. He is Owner and Chief Investment Officer of Closed End Strategies of Measure 8 Ventures Manage...

Leadership Team

NamePositionTenureCompensationOwnership
Boris Jordan
CEO & Chairmanless than a yearUS$12.35m17.37%
CA$ 285.1m
Joseph Lusardi
Executive Vice-Chairman6.2yrsUS$1.23m0.71%
CA$ 11.6m
Edward Kremer
Chief Financial Officer2.3yrsUS$2.76m0.033%
CA$ 540.2k
Peter Clateman
Chief Legal Officer4.8yrsUS$1.39m0.11%
CA$ 1.7m
Matthew Darin
Special Advisorless than a yearUS$5.18m0.57%
CA$ 9.4m
Camilo Lyon
Chief Investment Officer2.3yrsno datano data
Christine Taylor
Chief Accounting Officerless than a yearno datano data
Scott Baughman
Chief Technology Officerless than a yearno datano data
Jakob Feinstein
Manager of Investor Relationsno datano datano data
James Shorris
Chief Compliance Officer4.8yrsno datano data
Kate Lynch
Executive Vice President of Marketing3.9yrsno datano data

2.3yrs

Average Tenure

56yo

Average Age

Experienced Management: CURA's management team is considered experienced (2.3 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Boris Jordan
CEO & Chairman6.2yrsUS$12.35m17.37%
CA$ 285.1m
Joseph Lusardi
Executive Vice-Chairman6.2yrsUS$1.23m0.71%
CA$ 11.6m
Mitchell Kahn
Director4.4yrsUS$250.00k0.046%
CA$ 751.1k
Peter Derby
Independent Director6.2yrsUS$350.00k0.075%
CA$ 1.2m
Karl Johansson
Independent Director6.2yrsUS$350.00k0.019%
CA$ 310.7k
Robert Schnoll
Member of the Medical Advisory Boardno datano datano data
Jaswinder Grover
Independent Director4.8yrsUS$250.00k0.74%
CA$ 12.2m
Michelle Bodner
Director2yrsUS$250.00k0.039%
CA$ 642.3k
Shasheen Shah
Independent Director2yrsUS$250.00k0.0089%
CA$ 145.8k

5.5yrs

Average Tenure

60.5yo

Average Age

Experienced Board: CURA's board of directors are considered experienced (5.5 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/30 09:25
End of Day Share Price 2024/12/27 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Curaleaf Holdings, Inc. is covered by 23 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Aaron GreyAlliance Global Partners
Kenric TygheATB Capital Markets
Frederico Yokota Choucair GomesATB Capital Markets